a syndrome , including microangiopathic hemolytic anemia ( maha ) , thrombocytopenia , and renal insufficiency , has been recognized to occur as a complication of antineoplastic therapy with mitomycin .
C0040034
thrombocytopenia
C0002475
mitomycin